Transcranial cytokine gradients in patients requiring intensive care after acute brain injury
- PMID: 9175965
- DOI: 10.1093/bja/78.5.520
Transcranial cytokine gradients in patients requiring intensive care after acute brain injury
Abstract
After acute brain injury there may be increased intracranial production of cytokines, with activation of inflammatory cascades. We have sought to determine if a transcranial cytokine gradient was demonstrable in paired sera of 32 patients requiring intensive care after acute brain injury. The difference between concentrations of IL-1 beta, IL-6, IL-8 and TNF alpha in jugular venous and arterial serum was measured on admission, and at 24, 48 and 96 h after the primary injury. There were no differences in IL-1 beta, IL-8 or TNF alpha, but median gradients of 6.7 and 11.5 pg ml-1 for IL-6 were demonstrated in the traumatic brain injury (n = 22) and subarachnoid haemorrhage (n = 10) groups, respectively (normal values in serum < 4.7 pg ml-1; P < 0.001 both groups). This suggests that there is significant production of IL-6 by intracranial cells after acute brain injury. Therapy directed towards combatting the negative effects of IL-6 may potentially benefit patients who have sustained an acute brain injury.
Similar articles
-
Trauma-induced secondary cardiac injury is associated with hyperacute elevations in inflammatory cytokines.Shock. 2013 May;39(5):415-20. doi: 10.1097/SHK.0b013e31828ded41. Shock. 2013. PMID: 23459112
-
Is circulating endotoxin the trigger for the systemic inflammatory response syndrome seen after injury?Ann Surg. 1997 May;225(5):530-41; discussion 541-3. doi: 10.1097/00000658-199705000-00010. Ann Surg. 1997. PMID: 9193181 Free PMC article.
-
Correlation between transcranial interleukin-6 gradient and outcome in patients with acute brain injury.Crit Care Med. 2003 Mar;31(3):933-8. doi: 10.1097/01.CCM.0000055370.66389.59. Crit Care Med. 2003. PMID: 12627008
-
Serum IL-1beta, sIL-2R, IL-6, IL-8 and TNF-alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment.Mediators Inflamm. 2001 Jun;10(3):109-15. doi: 10.1080/09629350123895. Mediators Inflamm. 2001. PMID: 11545247 Free PMC article.
-
Regulation of interleukin-1 in acute brain injury.Trends Pharmacol Sci. 2011 Oct;32(10):617-22. doi: 10.1016/j.tips.2011.06.002. Epub 2011 Jul 23. Trends Pharmacol Sci. 2011. PMID: 21788085 Review.
Cited by
-
Mitochondrial responses to brain death in solid organ transplant.Front Transplant. 2023 Mar 21;2:1082227. doi: 10.3389/frtra.2023.1082227. eCollection 2023. Front Transplant. 2023. PMID: 38993857 Free PMC article. Review.
-
Cyclooxygenase-2-specific inhibitor improves functional outcomes, provides neuroprotection, and reduces inflammation in a rat model of traumatic brain injury.Neurosurgery. 2005 Mar;56(3):590-604. doi: 10.1227/01.neu.0000154060.14900.8f. Neurosurgery. 2005. PMID: 15730585 Free PMC article.
-
SOFA is superior to MOD score for the determination of non-neurologic organ dysfunction in patients with severe traumatic brain injury: a cohort study.Crit Care. 2006;10(4):R115. doi: 10.1186/cc5007. Crit Care. 2006. PMID: 16882348 Free PMC article.
-
Systemic inflammation alters the neuroinflammatory response: a prospective clinical trial in traumatic brain injury.J Neuroinflammation. 2021 Sep 25;18(1):221. doi: 10.1186/s12974-021-02264-2. J Neuroinflammation. 2021. PMID: 34563211 Free PMC article. Clinical Trial.
-
Splenectomy does not affect the development of pneumonia following severe traumatic brain injury.Brain Behav Immun Health. 2019 Nov 14;1:100007. doi: 10.1016/j.bbih.2019.100007. eCollection 2020 Jan. Brain Behav Immun Health. 2019. PMID: 38377417 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical